Lack of CD45 expression has a strong prognostic value in patients with multiple myeloma receiving high-dose therapy

被引：0
|
作者：
Moreau, P
Robillard, N
Avet-Loiseau, H
Morineau, N
Pineau, D
Milpied, N
Mahé, B
Vigier, M
Rapp, MJ
Harousseau, JL
Bataille, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S9 / S10
页数：2
相关论文
共 50 条
  • [31] Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic features
    Kaufmann, H
    Ackermann, J
    Greinix, H
    Nösslinger, T
    Gisslinger, H
    Keck, A
    Ludwig, H
    Worel, N
    Kalhs, P
    Zielinski, C
    Drach, J
    ANNALS OF ONCOLOGY, 2003, 14 (11) : 1667 - 1672
  • [32] Infections in Patients with Multiple Myeloma in the Era of High-Dose Therapy and Novel Agents
    Nucci, Marcio
    Anaissie, Elias
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : 1211 - 1225
  • [33] Outpatient high-dose melphalan in multiple myeloma patients
    Kassar, Mohamad
    Medoff, Erin
    Seropian, Stuart
    Cooper, Dennis L.
    TRANSFUSION, 2007, 47 (01) : 115 - 119
  • [34] Proliferation of immature myeloma cells by interleukin-6 is associated with CD45 expression in human multiple myeloma
    Ishikawa, H
    Mahmoud, MS
    Fujii, R
    Abroun, S
    Kawano, MM
    LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) : 51 - 55
  • [35] CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations
    S Kumar
    S V Rajkumar
    T Kimlinger
    P R Greipp
    T E Witzig
    Leukemia, 2005, 19 : 1466 - 1470
  • [36] CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations
    Kumar, S
    Rajkumar, S
    Kimlinger, T
    Greipp, P
    Witzig, T
    LEUKEMIA, 2005, 19 (08) : 1466 - 1470
  • [37] Risk driven decision for high-dose therapy in multiple myeloma - No
    Goldschmidt, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 242 - 242
  • [38] PROGNOSTIC FACTORS WITH HIGH-DOSE MELPHALAN FOR REFRACTORY MULTIPLE-MYELOMA
    BARLOGIE, B
    ALEXANIAN, R
    SMALLWOOD, L
    CHESON, B
    DIXON, D
    DICKE, K
    CABANILLAS, F
    BLOOD, 1988, 72 (06) : 2015 - 2019
  • [39] AN INCREMENTAL RESPONSE TO HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA
    HAWKINS, T
    HORVATH, N
    RAWLING, C
    BAYLY, J
    ANDARY, V
    DYSON, P
    HO, J
    DART, G
    JUTTNER, C
    TO, L
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 759 - 759
  • [40] High-dose therapy and innovative approaches to treatment of multiple myeloma
    Barlogie, B
    SEMINARS IN HEMATOLOGY, 2001, 38 (02) : 21 - 27
12345